NanoTemper Technologies

Protein production teams, get ready to move faster and more efficiently to deliver high-quality recombinant proteins! We’re excited to bring you Andromeda X, now with Spectral Shift technology, to help you optimize protein expression for all of your drug discovery workflows. Learn more: https://bit.ly/3whayEf

In this recent paper from Nature, Researchers at the Arc Institute and The University of Tokyo have unveiled a novel mechanism for precise genomic rearrangements using bridge RNAs (bRNAs). Learn how Monolith was used in this groundbreaking article to measure binding affinities of IS621 RNP for donor and target DNA, as well as for donor and target DNA containing scrambled LD–RD and LT–RT regions. Read the full publication: https://lnkd.in/gZ_GM3i5

How does NanoTemper incorporate user feedback? Spoiler alert: your feedback is the main driver for our success. All our products are based on questions, on feedback from our customers. From you. We listen. We really listen carefully. And then our R&D team does the magic. What feedback do you have for me? #biotechnology #entrepreneurship #startup ————————— I am Philipp - founder, CEO & business angel. My bootstrapped company NanoTemper is a global leader for biophysical tools for biotech. Like my content? Click my name + follow + 🔔

Exciting news! We’re happy to introduce our new advisory board, made up of five esteemed experts in biotech. Their insights will drive us forward in developing cutting-edge tools for drug development while upholding our core values. Welcome aboard Bettina Berendsen, Oliver Klaeffling, Hanns-Christian Mahler, Michael Pohlscheidt, and Nikolai Ahrens! Learn about the advisory board: https://bit.ly/4cZmVEq

The first step in designing targeted protein degraders is single-point screening for warheads and ligase ligands. Getting this step right can be what makes the difference in getting a degrader to clinical trials. So, how do you make sure you’re getting this step right? ✅ Answer: Use biophysical tools early in the screening process! They provide more robust data than biochemical techniques and give you insight into the structure-activity relationships of your molecules. 💡 Now, what if there was a biophysical tool that is as fast and easy to use as biochemical techniques? Spectral Shift technology fits the bill — with in-solution, mass-independent affinity measurements, you can quickly and easily identify the best degrader candidates. Watch Jan Schnatwinkel’s webinar to learn more: https://bit.ly/462MBxZ

Bridging Worlds: Uniting with Our Team in Beijing Just wrapped up an unforgettable visit to our Beijing subsidiary! Spent quality time with each team member, diving deep into 1-on-1s to really connect. To explore new ways to enhance our products and partnerships in China. We focused heavily on tailoring our marketing strategies to better integrate with the global landscape. Especially to strengthen our local customer relationships and footprint. The culinary highlights? Savoring Beijing's famous hot pot and Peking Duck on separate evenings—a true taste of the local culture! Capped it all off with a nighttime bicycle tour through the sprawling cityscapes of Beijing. The vastness is truly impressive! Have a look at the snapshots from the trip. Here's to more visits like this, where we learn, share, and grow together. #biotechnology #entrepreneurship #startup ————————— I am Philipp - founder, CEO & business angel. My bootstrapped company NanoTemper is a global leader for biophysical tools for biotech. Like my content? Click my name + follow + 🔔

When screening biologics formulations, how do you select the characterization tools to use? Experts like Aaron Frimel from Thermo Fisher Scientific value tools with flexible throughput, robustness, and high data resolution to make confident decisions. Learn why Prometheus Panta is his go-to choice for simultaneous, multi-parameter stability characterization of biologics. Watch Aaron’s full interview: https://bit.ly/3Rv30VG

For scientists working at core facilities and CROs, here’s why leading cancer research scientists — like Andrey Bobkov from Conrad Prebys Center for Chemical Genomics — ultimately choose Monolith for binding affinity measurements: • Measure binding affinity free in solution • Spend less time and material to get your experiments working • Run assays whenever you want since there’s no fluidics to maintain • Study a wide range of interactions Learn about Monolith for binding affinity measurements: https://bit.ly/4c4mfhf

🎉 What a night to remember! We celebrated the grand opening of our new global headquarters in Munich with an unforgettable party, bringing together our team, the Munich biopharma community, and our amazing customers. 🌟
 Our new headquarters was designed with our team and customers in mind. Philipp Baaske, co-CEO, says, “The space fosters greater collaboration, innovation, and production capacity — to ultimately create more cutting-edge tools that help researchers create a world where every disease is treatable.”

 Thank you to everyone who joined the celebration!

Independence.. May the 4th is for Science Fiction. July the 4th is for us all. For humankind. July the 4th stands for liberty & independence. Independence is one of the highest goods for me. Independence is also key for our company NanoTemper. We want to only depent on our own will and decisions. We want to only depent on our customers. The market. We are independent of 3rd party revenue and growth goals. We are independent from venture capital, private equity, banks. We do not have to make someone else rich. We do have to create value for our users. NOT because someone says so. We do so, because we want. Independence rocks Not only today. Always. Happy Independence Day! #biotechnology #entrepreneurship #startup #drugdiscovery #biotechnology #entrepreneurship #startup ————————— I am Philipp - founder, CEO & business angel. My bootstrapped company NanoTemper is a global leader for biophysical tools for biotech. Like my content? Click my name + follow + 🔔